Laura BlairMedication Adherence
Frank X. PowersHealthcare Challenger Brands
Mike ViscelIncreasing Engagement
Bud BilanichSuccess Coach
Pat PurcellMeeting Engagement
Matthew DurhamOmnidynamic Marketing
Stacey GandlerBrand Nourishment
Frank BurrellScientific Storytelling
Anil BhaskarUnified Customer Experience
Thomas SheaProgrammatic Marketing
Amy GilesIncreasing Engagement
Brenda SnowAuthentic Patient Voice
BEKINDA®i 12 mg Phase II study successfully met its primary endpoint, improving primary efficacy ...
Username
Password
Remember Me
Username or Email